Skip to main content

Advertisement

Log in

Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

A 34-year-old woman at 18 weeks of gestation during her third pregnancy was diagnosed with Hodgkin lymphoma stage IVA. She was treated with standard ABVD and showed good response. After three-and-a-half courses of ABVD, she spontaneously delivered a healthy baby girl at 41 weeks of gestation. She continued chemotherapy after delivery. A total of six courses of ABVD were given. Complete remission was obtained and has continued for 6 months post chemotherapy. Neither mother nor child developed any infections during the observation period. The child has also shown no physiological or developmental abnormalities. Here, we describe the feasibility and safety of the ABVD regimen for the treatment of Hodgkin lymphoma, and discuss the optimal treatment strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Resnik R. Cancer during pregnancy. N Engl J Med. 1999;341:120–1.

    Article  PubMed  CAS  Google Scholar 

  2. Cardonick E, Iacobucci A. Use of chemotherapy during pregnancy. Lancet Oncol. 2004;5:283–91.

    Article  PubMed  CAS  Google Scholar 

  3. Pohlman B, Macklis RM. Lymphoma and pregnancy. Semin Oncol. 2000;27:657–66.

    PubMed  CAS  Google Scholar 

  4. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997;74:207–20.

    Article  PubMed  CAS  Google Scholar 

  5. Daly H, McCann SR, Hanratty TD, Temperley IJ. Successful pregnancy during combination chemotherapy for Hodgkin’s disease. Acta Haematol. 1980;64:154–6.

    Article  PubMed  CAS  Google Scholar 

  6. McCann SR, Daly H, Hanratty TD, Temperley IJ. Hodgkin’s disease and pregnancy. Acta Haematol. 1981;66:67–8.

    Article  PubMed  CAS  Google Scholar 

  7. Sagan D, Semczuk A, Lampka E. Combination chemotherapy for Hodgkin’s lymphoma during pregnancy: favorable outcome for mother and child. J Obstet Gynaecol Res. 2010;36:882–6.

    Article  PubMed  Google Scholar 

  8. Jones GL, Taylor PR, Windebank KP, Hoye NA, Lucraft H, Wood K, et al. Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin’s lymphoma in adolescents. Br J Cancer. 2007;97:29–36.

    Article  PubMed  CAS  Google Scholar 

  9. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol. 1991;36:243–8.

    Article  PubMed  CAS  Google Scholar 

  10. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173–7.

    Article  PubMed  CAS  Google Scholar 

  11. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer. 1992;65:114–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noriyoshi Iriyama.

About this article

Cite this article

Iriyama, N., Horikoshi, A., Tanaka, T. et al. Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen. Int J Hematol 94, 104–107 (2011). https://doi.org/10.1007/s12185-011-0876-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0876-x

Keywords

Navigation